-
2
-
-
0030610422
-
Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia
-
Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 9831-9835
-
-
Li, Y.C.1
Pirro, A.E.2
Amling, M.3
Delling, G.4
Baron, R.5
Bronson, R.6
Demay, M.B.7
-
3
-
-
0030763857
-
Mice lacking the vitamin D receptor exhibit impaired bone formation,uterine hypoplasia and growth retardation after weaning
-
Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation,uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396
-
(1997)
Nat Genet
, vol.16
, pp. 391-396
-
-
Yoshizawa, T.1
Handa, Y.2
Uematsu, Y.3
Takeda, S.4
Sekine, K.5
Yoshihara, Y.6
Kawakami, T.7
Arioka, K.8
Sato, H.9
Uchiyama, Y.10
Masushige, S.11
Fukamizu, A.12
Matsumoto, T.13
Kato, S.14
-
4
-
-
0032780531
-
The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets
-
Malloy PJ, Pike JW, Feldman D 1999 The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 20:156-188
-
(1999)
Endocr Rev
, vol.20
, pp. 156-188
-
-
Malloy, P.J.1
Pike, J.W.2
Feldman, D.3
-
5
-
-
33646549957
-
Hereditary 1,25- dihydroxyvitamin D resistant rickets
-
Feldman D, Pike JW, Glorieux F, eds, 2nd ed. San Diego: Elsevier;
-
Malloy PJ, Pike JW, Feldman D 2005 Hereditary 1,25- dihydroxyvitamin D resistant rickets. In: Feldman D, Pike JW, Glorieux F, eds. Vitamin D. 2nd ed. San Diego: Elsevier; 1207-1238
-
(2005)
Vitamin D
, pp. 1207-1238
-
-
Malloy, P.J.1
Pike, J.W.2
Feldman, D.3
-
6
-
-
33947176624
-
Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer
-
Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D 2007 Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer. J Steroid Biochem Mol Biol 103:694-702
-
(2007)
J Steroid Biochem Mol Biol
, vol.103
, pp. 694-702
-
-
Krishnan, A.V.1
Moreno, J.2
Nonn, L.3
Malloy, P.4
Swami, S.5
Peng, L.6
Peehl, D.M.7
Feldman, D.8
-
7
-
-
84884080872
-
Vitamin D: Biology, action, and clinical implications
-
Marcus R, Feldman D, Nelson DA, Rosen CJ, eds, 3rd ed. San Diego: Academic Press;
-
Feldman D, Malloy PJ, Krishnan AV, Balint E 2007 Vitamin D: biology, action, and clinical implications. In: Marcus R, Feldman D, Nelson DA, Rosen CJ, eds. Osteoporosis. 3rd ed. San Diego: Academic Press; 317-382
-
(2007)
Osteoporosis
, pp. 317-382
-
-
Feldman, D.1
Malloy, P.J.2
Krishnan, A.V.3
Balint, E.4
-
8
-
-
0031685620
-
TGF-β signal transduction
-
Massague J 1998 TGF-β signal transduction. Annu Rev Biochem 67:753-791
-
(1998)
Annu Rev Biochem
, vol.67
, pp. 753-791
-
-
Massague, J.1
-
9
-
-
0034994419
-
Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression
-
Clarke TR, Hoshiya Y, Yi SE, LiuX, Lyons KM, Donahoe PK 2001 Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 15:946 -959
-
(2001)
Mol Endocrinol
, vol.15
, pp. 946-959
-
-
Clarke, T.R.1
Hoshiya, Y.2
Yi, S.E.3
Liu, X.4
Lyons, K.M.5
Donahoe, P.K.6
-
10
-
-
0034982133
-
The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling
-
Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA 2001 The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol Endocrinol 15:936 -945
-
(2001)
Mol Endocrinol
, vol.15
, pp. 936-945
-
-
Visser, J.A.1
Olaso, R.2
Verhoef-Post, M.3
Kramer, P.4
Themmen, A.P.5
Ingraham, H.A.6
-
11
-
-
0346502851
-
Sex determination and differentiation
-
MacLaughlin DT, Donahoe PK 2004 Sex determination and differentiation. N Engl J Med 350:367-378
-
(2004)
N Engl J Med
, vol.350
, pp. 367-378
-
-
MacLaughlin, D.T.1
Donahoe, P.K.2
-
12
-
-
0037731743
-
Transduction pathwayof anti-Mullerian hormone, a sex-specific member of the TGF-β family
-
Josso N, Clemente N2003 Transduction pathwayof anti-Mullerian hormone, a sex-specific member of the TGF-β family. Trends Endocrinol Metab 14:91-97
-
(2003)
Trends Endocrinol Metab
, vol.14
, pp. 91-97
-
-
Josso, N.1
Clemente, N.2
-
13
-
-
0035853106
-
Mullerian inhibiting substance lowers testosterone in luteinizing hormone-stimulated rodents
-
Trbovich AM, Sluss PM, Laurich VM, O'Neill FH, MacLaughlin DT, Donahoe PK, Teixeira J 2001 Mullerian inhibiting substance lowers testosterone in luteinizing hormone-stimulated rodents. Proc Natl Acad Sci USA 98:3393-3397
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 3393-3397
-
-
Trbovich, A.M.1
Sluss, P.M.2
Laurich, V.M.3
O'Neill, F.H.4
MacLaughlin, D.T.5
Donahoe, P.K.6
Teixeira, J.7
-
14
-
-
0345377818
-
Inhibition of steroidogenesis in Leydig cells by Mullerian-inhibiting substance
-
Fynn-Thompson E, Cheng H, Teixeira J 2003 Inhibition of steroidogenesis in Leydig cells by Mullerian-inhibiting substance. Mol Cell Endocrinol 211:99 -104
-
(2003)
Mol Cell Endocrinol
, vol.211
, pp. 99-104
-
-
Fynn-Thompson, E.1
Cheng, H.2
Teixeira, J.3
-
15
-
-
0035172184
-
Mullerian inhibitory substance induces growth of rat preantral ovarian follicles
-
McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H, Hsueh AJ 2001 Mullerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod 64:293-298
-
(2001)
Biol Reprod
, vol.64
, pp. 293-298
-
-
McGee, E.A.1
Smith, R.2
Spears, N.3
Nachtigal, M.W.4
Ingraham, H.5
Hsueh, A.J.6
-
16
-
-
0036171566
-
Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary
-
Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP 2002 Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076 -1084
-
(2002)
Endocrinology
, vol.143
, pp. 1076-1084
-
-
Durlinger, A.L.1
Gruijters, M.J.2
Kramer, P.3
Karels, B.4
Ingraham, H.A.5
Nachtigal, M.W.6
Uilenbroek, J.T.7
Grootegoed, J.A.8
Themmen, A.P.9
-
17
-
-
34347218225
-
The Anti-Mullerian hormone and ovarian cancer
-
La Marca A, Volpe A 2007 The Anti-Mullerian hormone and ovarian cancer. Hum Reprod Update 13:265-273
-
(2007)
Hum Reprod Update
, vol.13
, pp. 265-273
-
-
La Marca, A.1
Volpe, A.2
-
18
-
-
33751251989
-
Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer
-
Pieretti-Vanmarcke R, Donahoe PK, Pearsall LA, Dinulescu DM, Connolly DC, Halpern EF, Seiden MV, MacLaughlin DT 2006 Mullerian inhibiting substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proc Natl Acad Sci USA 103:17426 -17431
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 17426-17431
-
-
Pieretti-Vanmarcke, R.1
Donahoe, P.K.2
Pearsall, L.A.3
Dinulescu, D.M.4
Connolly, D.C.5
Halpern, E.F.6
Seiden, M.V.7
MacLaughlin, D.T.8
-
19
-
-
11844288346
-
Endo- metrial cancer is a receptor-mediated target for Mullerian inhibiting substance
-
Renaud EJ, MacLaughlin DT, Oliva E, Rueda BR, Donahoe PK 2005 Endo- metrial cancer is a receptor-mediated target for Mullerian inhibiting substance. Proc Natl Acad Sci USA 102:111-116
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 111-116
-
-
Renaud, E.J.1
MacLaughlin, D.T.2
Oliva, E.3
Rueda, B.R.4
Donahoe, P.K.5
-
20
-
-
0344946474
-
Mullerian inhibiting substance induces NFkB signaling in breast and prostate cancer cells
-
Hoshiya Y, Gupta V, Segev DL, Hoshiya M, Carey JL, Sasur LM, Tran TT, Ha TU, Maheswaran S 2003 Mullerian inhibiting substance induces NFkB signaling in breast and prostate cancer cells. Mol Cell Endocrinol 211:43-49
-
(2003)
Mol Cell Endocrinol
, vol.211
, pp. 43-49
-
-
Hoshiya, Y.1
Gupta, V.2
Segev, D.L.3
Hoshiya, M.4
Carey, J.L.5
Sasur, L.M.6
Tran, T.T.7
Ha, T.U.8
Maheswaran, S.9
-
21
-
-
0347364642
-
Mullerian inhibiting substance inhibits cervical cancer cell growth via a pathway involving p130 and p107
-
Barbie TU, Barbie DA, MacLaughlin DT, Maheswaran S, Donahoe PK 2003 Mullerian inhibiting substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci USA 100:15601-15606
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 15601-15606
-
-
Barbie, T.U.1
Barbie, D.A.2
MacLaughlin, D.T.3
Maheswaran, S.4
Donahoe, P.K.5
-
22
-
-
0036023430
-
Highly purified Mullerian inhibiting substance inhibits human ovarian cancer in vivo
-
StephenAE, PearsallLA, ChristianBP, Donahoe PK, Vacanti JP, MacLaughlin DT 2002 Highly purified Mullerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res 8:2640-2646
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2640-2646
-
-
Stephen, A.E.1
Pearsall, L.A.2
Christian, B.P.3
Donahoe, P.K.4
Vacanti, J.P.5
MacLaughlin, D.T.6
-
23
-
-
0037039385
-
Mullerian-inhibiting substance regulates NF-κB signaling in the prostate in vitro and in vivo
-
Segev DL, Hoshiya Y, Hoshiya M, Tran TT, Carey JL, Stephen AE, MacLaughlin DT, Donahoe PK, Maheswaran S 2002 Mullerian-inhibiting substance regulates NF-κB signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci USA 99:239-244
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 239-244
-
-
Segev, D.L.1
Hoshiya, Y.2
Hoshiya, M.3
Tran, T.T.4
Carey, J.L.5
Stephen, A.E.6
MacLaughlin, D.T.7
Donahoe, P.K.8
Maheswaran, S.9
-
24
-
-
0034665859
-
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFκB-mediated pathway
-
Segev DL, Ha TU, Tran TT, Kenneally M, Harkin P, Jung M, MacLaughlin DT, Donahoe PK, MaheswaranS 2000 Mullerian inhibiting substance inhibits breast cancer cell growth through an NFκB-mediated pathway. J Biol Chem 275:28371-28379
-
(2000)
J Biol Chem
, vol.275
, pp. 28371-28379
-
-
Segev, D.L.1
Ha, T.U.2
Tran, T.T.3
Kenneally, M.4
Harkin, P.5
Jung, M.6
MacLaughlin, D.T.7
Donahoe, P.K.8
MaheswaranS9
-
25
-
-
0036844298
-
A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia
-
Malloy PJ, Xu R, Peng L, Clark PA, Feldman D 2002 A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Mol Endocrinol 16:2538 -2546
-
(2002)
Mol Endocrinol
, vol.16
, pp. 2538-2546
-
-
Malloy, P.J.1
Xu, R.2
Peng, L.3
Clark, P.A.4
Feldman, D.5
-
26
-
-
0029084077
-
The genes for a spliceosome protein (SAP62) and the anti-Mullerian hormone (AMH) are contiguous
-
Dresser DW, Hacker A, Lovell-Badge R, Guerrier D 1995 The genes for a spliceosome protein (SAP62) and the anti-Mullerian hormone (AMH) are contiguous. Hum Mol Genet 4:1613-1618
-
(1995)
Hum Mol Genet
, vol.4
, pp. 1613-1618
-
-
Dresser, D.W.1
Hacker, A.2
Lovell-Badge, R.3
Guerrier, D.4
-
27
-
-
0028308118
-
Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: A link to the sex determination cascade
-
Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA 1994 Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77:651-661
-
(1994)
Cell
, vol.77
, pp. 651-661
-
-
Shen, W.H.1
Moore, C.C.2
Ikeda, Y.3
Parker, K.L.4
Ingraham, H.A.5
-
28
-
-
10544241193
-
3: Point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner
-
3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Mol Endocrinol 10:1617-1631
-
(1996)
Mol Endocrinol
, vol.10
, pp. 1617-1631
-
-
Whitfield, G.K.1
Selznick, S.H.2
Haussler, C.A.3
Hsieh, J.C.4
Galligan, M.A.5
Jurutka, P.W.6
Thompson, P.D.7
Lee, S.M.8
Zerwekh, J.E.9
Haussler, M.R.10
-
29
-
-
20444472759
-
Anti-Mullerian hormone: Its role in follicular growth initiation and survival and as an ovarian reserve marker
-
Review
-
Themmen AP 2005 Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 34:18 -21 (Review)
-
(2005)
J Natl Cancer Inst Monogr
, vol.34
, pp. 18-21
-
-
Themmen, A.P.1
-
30
-
-
33745751952
-
Testicular anti-Mullerian hormone: History, genetics, regulation and clinical applications
-
Josso N, Picard JY, Rey R, di Clemente N 2006 Testicular anti-Mullerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 3:347-358
-
(2006)
Pediatr Endocrinol Rev
, vol.3
, pp. 347-358
-
-
Josso, N.1
Picard, J.Y.2
Rey, R.3
di Clemente, N.4
-
31
-
-
0036153430
-
Relationship between serum Mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women
-
Cook CL, Siow Y, Brenner AG, Fallat ME 2002 Relationship between serum Mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 77:141-146
-
(2002)
Fertil Steril
, vol.77
, pp. 141-146
-
-
Cook, C.L.1
Siow, Y.2
Brenner, A.G.3
Fallat, M.E.4
-
32
-
-
0242479340
-
Elevated serum level of anti-Mullerian hormone in patients with poly- cystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest
-
Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D 2003 Elevated serum level of anti-Mullerian hormone in patients with poly- cystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88:5957-5962
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5957-5962
-
-
Pigny, P.1
Merlen, E.2
Robert, Y.3
Cortet-Rudelli, C.4
Decanter, C.5
Jonard, S.6
Dewailly, D.7
-
33
-
-
33846042785
-
Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries
-
PellattL, Hanna L, Brincat M, Galea R, BrainH, Whitehead S, Mason H 2007 Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 92:240 -245
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 240-245
-
-
Pellatt, L.1
Hanna, L.2
Brincat, M.3
Galea, R.4
Brain, H.5
Whitehead, S.6
Mason, H.7
-
34
-
-
33846259778
-
-
Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA 2007 Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol 196:77e1-77e5
-
Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA 2007 Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol 196:77e1-77e5
-
-
-
-
35
-
-
0141961566
-
Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling
-
Hsieh JC, Sisk JM, Jurutka PW, Haussler CA, Slater SA, Haussler MR, Thompson CC 2003 Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J Biol Chem 278:38665-38674
-
(2003)
J Biol Chem
, vol.278
, pp. 38665-38674
-
-
Hsieh, J.C.1
Sisk, J.M.2
Jurutka, P.W.3
Haussler, C.A.4
Slater, S.A.5
Haussler, M.R.6
Thompson, C.C.7
-
36
-
-
0032076964
-
Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
-
Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA 1998 Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93:445-454
-
(1998)
Cell
, vol.93
, pp. 445-454
-
-
Nachtigal, M.W.1
Hirokawa, Y.2
Enyeart-VanHouten, D.L.3
Flanagan, J.N.4
Hammer, G.D.5
Ingraham, H.A.6
-
37
-
-
0029838859
-
Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent mullerian ducts in a Turkish boy born to consanguineous parents
-
Van Maldergem L, Bachy A, Feldman D, Bouillon R, Maassen J, Dreyer M, Rey R, Holm C, Gillerot Y 1996 Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent mullerian ducts in a Turkish boy born to consanguineous parents. Am J Med Genet 64:506 -513
-
(1996)
Am J Med Genet
, vol.64
, pp. 506-513
-
-
Van Maldergem, L.1
Bachy, A.2
Feldman, D.3
Bouillon, R.4
Maassen, J.5
Dreyer, M.6
Rey, R.7
Holm, C.8
Gillerot, Y.9
-
38
-
-
0031038088
-
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness
-
Malloy PJ, Eccleshall TR, Gross C, Van Maldergem L, Bouillon R, Feldman D 1997 Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest 99:297-304
-
(1997)
J Clin Invest
, vol.99
, pp. 297-304
-
-
Malloy, P.J.1
Eccleshall, T.R.2
Gross, C.3
Van Maldergem, L.4
Bouillon, R.5
Feldman, D.6
-
39
-
-
0034941121
-
-
Magre J, Delepine M, Khallouf E, Gedde-Dahl Jr T, Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, AssanR, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F,deKerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, et al. 2001 Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365-370
-
Magre J, Delepine M, Khallouf E, Gedde-Dahl Jr T, Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, AssanR, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F,deKerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, et al. 2001 Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365-370
-
-
-
-
40
-
-
34147092113
-
Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases
-
Ito D, Suzuki N 2007 Molecular pathogenesis of seipin/BSCL2-related motor neuron diseases. Ann Neurol 61:237-250
-
(2007)
Ann Neurol
, vol.61
, pp. 237-250
-
-
Ito, D.1
Suzuki, N.2
-
43
-
-
0021288021
-
Production of anti- Mullerian hormone: Another homology between Sertoli and granulosa cells
-
Vigier B, Picard JY, Tran D, Legeai L, Josso N 1984 Production of anti- Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114:1315-1320
-
(1984)
Endocrinology
, vol.114
, pp. 1315-1320
-
-
Vigier, B.1
Picard, J.Y.2
Tran, D.3
Legeai, L.4
Josso, N.5
-
44
-
-
0022779720
-
The ontogeny of Mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle
-
Takahashi M, Hayashi M, Manganaro TF, Donahoe PK 1986 The ontogeny of Mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol Reprod 35:447-453
-
(1986)
Biol Reprod
, vol.35
, pp. 447-453
-
-
Takahashi, M.1
Hayashi, M.2
Manganaro, T.F.3
Donahoe, P.K.4
-
45
-
-
43549115464
-
Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture
-
Grossman MP, Nakajima ST, Fallat ME, Siow Y 2008 Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril 89:1364-1370
-
(2008)
Fertil Steril
, vol.89
, pp. 1364-1370
-
-
Grossman, M.P.1
Nakajima, S.T.2
Fallat, M.E.3
Siow, Y.4
-
46
-
-
43149095105
-
The role of Mullerian inhibiting substance in female reproduction
-
Nakhuda GS 2008 The role of Mullerian inhibiting substance in female reproduction. Curr Opin Obstet Gynecol 20:257-264
-
(2008)
Curr Opin Obstet Gynecol
, vol.20
, pp. 257-264
-
-
Nakhuda, G.S.1
-
47
-
-
0034456885
-
Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads
-
Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y 2000 Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141:1317-1324
-
(2000)
Endocrinology
, vol.141
, pp. 1317-1324
-
-
Kinuta, K.1
Tanaka, H.2
Moriwake, T.3
Aya, K.4
Kato, S.5
Seino, Y.6
-
48
-
-
0035912707
-
Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction
-
Panda DK, Miao D, TremblayML, Sirois J, Farookhi R, Hendy GN, Goltzman D 2001 Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 98:7498-7503
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 7498-7503
-
-
Panda, D.K.1
Miao, D.2
Tremblay, M.L.3
Sirois, J.4
Farookhi, R.5
Hendy, G.N.6
Goltzman, D.7
-
49
-
-
0242626130
-
Aromatase in bone: Roles of vitamin D3 and androgens
-
Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H 2003 Aromatase in bone: roles of vitamin D3 and androgens. J Steroid Biochem Mol Biol 86:393-397
-
(2003)
J Steroid Biochem Mol Biol
, vol.86
, pp. 393-397
-
-
Yanase, T.1
Suzuki, S.2
Goto, K.3
Nomura, M.4
Okabe, T.5
Takayanagi, R.6
Nawata, H.7
-
50
-
-
0034798865
-
Mullerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications
-
Teixeira J, Maheswaran S, Donahoe PK 2001 Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22:657-674
-
(2001)
Endocr Rev
, vol.22
, pp. 657-674
-
-
Teixeira, J.1
Maheswaran, S.2
Donahoe, P.K.3
-
51
-
-
0344515663
-
Enhanced purification and production of Mullerian inhibiting substance for therapeutic applications
-
Donahoe PK, Clarke T, Teixeira J, Maheswaran S, MacLaughlin DT 2003 Enhanced purification and production of Mullerian inhibiting substance for therapeutic applications. Mol Cell Endocrinol 211:37-42
-
(2003)
Mol Cell Endocrinol
, vol.211
, pp. 37-42
-
-
Donahoe, P.K.1
Clarke, T.2
Teixeira, J.3
Maheswaran, S.4
MacLaughlin, D.T.5
-
52
-
-
85047678455
-
Mullerian-in- hibiting substance regulates androgen synthesis at the transcriptional level
-
Teixeira J, Fynn-Thompson E, Payne AH, Donahoe PK 1999 Mullerian-in- hibiting substance regulates androgen synthesis at the transcriptional level. Endocrinology 140:4732-4738
-
(1999)
Endocrinology
, vol.140
, pp. 4732-4738
-
-
Teixeira, J.1
Fynn-Thompson, E.2
Payne, A.H.3
Donahoe, P.K.4
|